Rockefeller Capital Management L.P. Alaunos Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.41 - $1.24 $3,038 - $9,188	7,410 Added 741.0%	8,410 $10,000
Q1 2021 May 11, 2021	BUY	$2.82 - $5.6 $2,820 - $5,600	1,000 New	1,000 $3,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $32,106 - $47,468	-15,362 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $27,874 - $40,004	-11,663 Reduced 43.16%	15,362 $38,000
Q2 2020 Aug 12, 2020	BUY	$2.2 - $3.71 $51,315 - $86,535	23,325 Added 630.41%	27,025 $89,000
Q1 2020 May 12, 2020	BUY	$1.9 - $4.98 $7,030 - $18,426	3,700 New	3,700 $9,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $352M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.